Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 274 of 6351
-
Can a radioactive 'Smart Bomb' take down resistant childhood cancers?
Disease control Expanded accessThis is an expanded access protocol/compassionate use single institution study designed to determine the palliative benefit and toxicity of 131I-MIBG in patients with progressive neuroblastoma and metastatic pheochromocytoma who are not eligible for therapies of higher priority. …
Sponsor: Northwell Health • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a weekly brain infusion slow sanfilippo syndrome?
Disease control Expanded accessThis is an intermediate-size patient population Early Access Program (EAP) providing access to intracerebroventricular (ICV) tralesinidase alfa (TA) for participants with mucopolysaccharidosis type IIIB (MPS IIIB, Sanfilippo Syndrome Type B). The primary objectives are to allow e…
Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Cow-Hemoglobin drug offers hope for anemia patients who refuse blood
Disease control Expanded access (ended)The purpose of this protocol is to provide treatment with HBOC-201 to patients with life-threatening anemia for whom allogeneic blood transfusion is not an option. HBOC 201 \[hemoglobin glutamer - 250 (bovine)\] has been previously studied as an alternative to blood transfusions …
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug combo aims to tackle bipolar depression and suicidal thoughts
Disease control Expanded accessThe purpose of this Expanded Access Treatment Protocol is to make NRX-101 available to patients who have treatment-resistant depression and who are unable to participate in, or do not have access to, the ongoing NRX-101 clinical trial. The objective of the program is to provide t…
Sponsor: NeuroRx, Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New stem cell processing method offers hope for patients without a perfect donor match
Disease control Expanded accessThe primary objective of this protocol is to expand access for patients who lack a fully HLA (Human leukocyte antigen) matched sibling donor, and who are candidates for allogeneic hematopoietic stem cell transplant (HSCT). These patients have a serious or immediately life-threate…
Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New daily pill could help millions shed pounds and control diabetes
Disease control OngoingThe purpose of this Master Protocol is to support two studies to see how well and how safely orforglipron works compared to placebo in participants who have obesity or overweight with or without type 2 diabetes. Participants will be screened for about 4 weeks, after which they wi…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New vaccine aims to protect infants from deadly diarrhea
Vaccine CompletedIn this study, the tetravalent bioconjugate candidate vaccine Shigella4V will be tested to obtain first-in-human data on its safety and immunogenicity in infants and to identify the preferred dose of Shigella4V in 9 month old infants.
Phase 1/2 • Sponsor: LimmaTech Biologics AG • Aim: Vaccine
Last updated Jun 27, 2026 14:03 UTC
-
Can a growth factor rebuild leg arteries and ease pain?
Disease control Not yet recruitingFGF-1 for the treatment of patients with peripheral arterial disease with intermittent claudication.
Phase 1/2 • Sponsor: Venturis Therapeutics, Inc. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can adding nurses to primary care boost quality of life?
Disease control Not yet recruitingAccess to primary care in France is increasingly constrained due to demographic changes, regional disparities in physician distribution, and the rising prevalence of chronic diseases. APNs were introduced to improve access to care and the coordination of patient management. While…
Sponsor: Le Mans Universite • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could a single sauna session lift depression and anxiety?
Symptom relief Not yet recruitingThis study aims to examine the scientific mechanisms of whole-body hyperthermia (WBH), a novel, rapidly acting, single session antidepressant and anxiolytic therapy. It also aims to determine its feasibility and acceptability in women with postpartum depression (PPD). The study w…
Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
A vibrating belt might soothe the back pain that plagues desk jobs
Symptom relief Not yet recruitingThis randomized, double-blind, sham-controlled trial will evaluate the effectiveness of a sensory stimulation belt in office workers with chronic nonspecific low back pain. Participants will first complete baseline clinical and sensorimotor assessments and will then be randomly a…
Sponsor: Mahidol University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Could a stem cell shot before birth fix fanconi anemia?
Disease control Not yet recruitingThe investigators aim to evaluate the safety and efficacy of in utero hematopoietic stem cell transplantation (IUHSCT) for the treatment of fetuses diagnosed with Fanconi anemia (FA) during pregnancy.
Phase 1/2 • Sponsor: Agnieszka Czechowicz • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
A digital toolkit takes on gym culture's body pressure for teen boys
Prevention Not yet recruitingThe purpose of this study is to evaluate whether a digital intervention can improve body image and psychological well-being among adolescent boys who attend fitness clubs. Fitness club environments and social media often promote appearance ideals related to muscularity and leanne…
Sponsor: Norwegian School of Sport Sciences • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
AI could personalize emergency treatment for deadly aortic tears
Disease control Not yet recruitingAortic dissection has acute onset and high mortality, with immunoinflammatory response driving lesion progression. Current perioperative anti-inflammatory therapies are mostly empirical and poorly targeted, and AI-assisted typing lacks a complete clinical translation pathway. Thi…
Sponsor: Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New combo therapy before surgery shows promise for bile duct cancer
Disease control Not yet recruitingThis phase II trial tests the safety and effectiveness of preoperative immunotherapy with durvalumab and chemotherapy with cisplatin and gemcitabine with or without futibatinib targeted therapy in treating patients with intrahepatic cholangiocarcinoma that can be removed by surge…
Phase 2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a pharmacist and text messages help smokers quit even when they're not ready?
Disease control Not yet recruitingThis study uses a factorial optimization experiment to identify which treatment components help adults who smoke and are not ready to quit in the next 30 days (smokers not ready to quit, or SNRTQ) achieve smoking cessation. Participants are recruited through Federally Qualified H…
Sponsor: University of Virginia • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New pill combo aims to tame tough leukemia
Disease control Not yet recruitingThe goal of Part 1 of this clinical research study is to find the highest tolerable dose of cladribine that can be given in combination with low dose cytarabine (LDAC) and venetoclax to patients who have AML. The goal of Part 2 of this clinical research study is to learn if the …
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can your own fat cells rebuild a damaged knee?
Disease control Not yet recruitingThis is an multi-center study with the aim of evaluating the efficacy of adipose tissue processed with the SyntrFuge™ system in Orthopedic Surgery, specifically Knee Osteoarthritis. Patients will be enrolled to the treatment group with adipose tissue processed with the SyntrFuge™…
Sponsor: Syntr Health Technologies, Inc. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Texts and local mentors: a new way to empower teen girls on contraception?
Prevention Not yet recruitingThe PREVENT Project is a multifaceted, adolescent friendly, culturally competent program aimed to address the issues surrounding unplanned pregnancies and lack of access and uptake of contraceptive services among adolescent girls. The intervention uses a mobile platform that prov…
Sponsor: Dr. Karen Yeates • Aim: Prevention
Last updated Aug 14, 2026 00:00 UTC
-
Magnetic brain zaps tailored to each patient may boost memory in Alzheimer's
Symptom relief Not yet recruitingBackground: Alzheimer's disease is a major health problem in our society. To date, pharmacological treatments to reduce Alzheimer's disease symptoms have obtained poor results and there is a growing interest in finding non-pharmacological treatments for this impactful disease. Tr…
Sponsor: Universitat Oberta de Catalunya • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC